Navigation Links
Rapid Adoption of Carterra’s LSA™ Instrument Drives European Expansion
Date:8/14/2019

Carterra® Inc., the world leader in high-throughput antibody screening and characterization, announced today that they have opened a Customer Experience Center (CEC) and office in Munich, Germany. Rapid European adoption of Carterra’s platform has fueled the need for the new office.

The Munich CEC will be a place for researchers throughout Europe to gain first-hand experience with Carterra’s game-changing antibody screening platform, the LSA, through demonstrations and workshops. Carterra will also offer basic courses in label-free biosensor operation, experimental design, and data analysis. Since its launch in 2018, the LSA is installed on three continents and in a majority of the largest pharmaceutical companies in the world. To support this exponential worldwide growth, Carterra has hired direct sales, support, and service personnel in Europe, most of whom are based in the Munich office.

Traditional antibody discovery requires a primary screen of ever-expanding antibody libraries by low-resolution “yes/no” assays to identify binders. Only a small group of candidate antibodies are then characterized on traditional, low-throughput biosensor tools, which provide real-time readout of the full binding profile. This workflow runs the risk that potential blockbuster drug candidates could be missed.

Carterra’s LSA is turning that model on its head by enabling the high-resolution analysis of entire libraries, combining screening and characterization into one seamless step, thereby minimizing the risk of missing a blockbuster. The LSA’s dramatic throughput condenses months of work into days.

Additionally, the LSA offers investigators the most resolved view of the epitope – the location an antibody binds to its target. An epitope is an innate property that cannot be changed and must be discovered empirically. The LSA is the only technology that enables characterization of epitope binding at the full library level. This provides biologics developers an enormous advantage in differentiating their biomolecules from competitors’ drugs and in establishing intellectual property claims.

“The LSA is changing the way biologics are discovered,” says Tim Germann, Carterra’s Chief Commercial Officer. “We’re thrilled to invite European drug developers and the research community at large to experience in person the massive throughput and minuscule sample requirements that the LSA enables. We’re making the traditional discovery processes up to 100 times faster while using only 1% of the normal sample input--it’s the definition of disruptive.”

About Carterra, Inc.
Carterra® is the leading provider of high throughput technologies designed to accelerate and improve the discovery of novel therapeutic candidates. Carterra’s LSA™ instrument, software, and consumables for monoclonal antibody (mAb) characterization deliver up to 100 times the throughput of existing platforms in 10% of the time while using only 1% of the sample required by other systems. The LSA combines patented microfluidics technology with real-time high throughput Surface Plasmon Resonance (HT-SPR) and industry-leading data analysis and visualization software to revolutionize mAb screening. Carterra, Inc. is based in Salt Lake City Utah, and has Customer Experience Centers in Dublin, California, Newtown, Pennsylvania, and Munich, Germany. For additional information, please visit http://www.carterra-bio.com.

Read the full story at https://www.prweb.com/releases/rapid_adoption_of_carterras_lsa_instrument_drives_european_expansion/prweb16504272.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. SeqOnce Biosciences Launches RhinoSeq™ Rapid DNA Library Preparation Kit
2. KICVentures Ramps Up AxioMed Freedom Cervical Disc Manufacturing to Meet OUS Orders and Expand Market Share Rapidly
3. RxS Expands its Office Footprint to Accommodate Rapid Growth
4. Boekel Scientific rapidFISH Hybridization Oven Used to Study the Effects of Humidity on a DNA Labeling System
5. The Human Microbiome: Advancing New Frontiers in a Rapidly Emerging Market
6. Counting fish teeth reveals regulatory DNA changes behind rapid evolution, adaptation
7. Whats for dinner? Rapidly identifying undescribed species in a commercial fungi packet
8. Sponsors And CROs Rapidly Adopting MedNet Solutions eClinical Technology Platform
9. Scientists develop electronic nose for rapid detection of C. diff infection
10. Researcher using next-generation sequencing to rapidly identify pathogens
11. Widespread support for rapid HIV testing in dental surgeries -- new study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2019)... ... August 20, 2019 , ... Scientists ranked New England ... first fielded the survey in 2016. The results are published in the ... part of Science and Medicine Group. More than 800 life scientists were asked ...
(Date:8/15/2019)... , ... August 15, 2019 , ... ... and relieve lab staff of routine tasks. That was the message at the ... market researcher Kalorama Information. The American Association for Clinical Chemistry (AACC) Annual Scientific ...
(Date:8/14/2019)... , ... August 14, 2019 , ... Representatives with MyBioGate ... and Exhibition Center in Boston. , “We help innovative projects connect with Chinese pharma ... for MyBioGate. , Guo went on to explain that as a part of Biotech ...
Breaking Biology News(10 mins):
(Date:9/17/2019)... ... September 17, 2019 , ... Geneticure, Inc., a Rochester Minnesota ... that the U.S. Patent and Trademark Office (USPTO) and European Patent Office (EPO) ... recommendations for hypertension treatment. , The patent applies to Geneticure’s first pharmacogenomics ...
(Date:9/17/2019)... STATION, N.J. (PRWEB) , ... September 16, 2019 , ... ... clearing reagents and kits that allow for the complete 3D characterization of tissues through ... Visikol has transitioned into an imaging, image analysis and advanced cell culture focused contract ...
(Date:9/17/2019)... ... September 16, 2019 , ... ... the China Focus @ Biotech Week Boston, a forum organized by MyBioGate, Inc. ... healthcare innovation. , After a careful process of evaluation, twelve companies out of ...
(Date:9/11/2019)... ... September 09, 2019 , ... Suvoda LLC , ... drug supply chain management, today announced its new technology partnership with Veeva ... “The integration between Veeva Vault EDC and our IRT will enable sponsors and ...
Breaking Biology Technology: